Rating History for Intellia Therapeutics (NTLA) by Barclays

More Stocks Rated by Barclays | Latest Ratings for NTLA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/6/2026 Gena Wang New Coverage Underweight
(N/A)		 8.00
(N/A)		 12.75
(11.42)		 -10.43% Details